Xenical 120mg Capsules,when used in conjunction with a reduced-calorie diet, can be used for obesity management, including weight loss and weight maintenance.Xenicalworks in your digestive system to block one-third of the fat in the food you eat from being digestedThe daily intake of fat, carbohydrate and protein should be distributed over three main meals.pills can also block the absorption of some vitamins. You may wish to take a multivitamin supplement along with making sure to keep a well-balanced diet, rich in fruit and vegetables.
The active substance isOrlistat. Each capsule contains120 mg of Orlistat
The other ingredients are microcrystalline cellulose (E460), sodium starch glycolate (type A), povidone (E1201), sodium laurilsulfate and talc. The capsule shell consists of gelatine, indigo carmine (E132), titanium dioxide (E171) and edible printing ink.
84 Capsules
WeizingOutOurmittedlyaxicontinatezenalivexicosapnaqoayettex
ima
nora
jul
Common side effects may include:
Serious side effects you may experience from taking orlistat can be divided into:
You should stop taking Xenical immediately and seek emergency medical attention if any of the side effects worsen:
einaidia
Xenical 120mg Capsules, Xenical 120mg Capsules, Xenical 120mg Capsules, Xenical 120mg CapsulesStore at 30°C and out of reach of children. Store in the original package in order to protect from moisture. Keep the carton.
Most side effects are not serious and do not require medical attention and will go away once the course is over.
You may experience some common side effects, but they are not limited
Dietary fats are large molecules that need to be broken down before they can be absorbed into the body. They are broken down by enzymes called lipases. That is, lipases play an important role in the digestion of dietary fat. When taken with a meal, Xenical interferes with the activity of these enzymes. This allows about 30% of the fat eaten in the meal to pass through the gut undigested. Therefore, your body cannot store these excess calories as fatty tissue or use them as a source of energy. This helps you to reduce your weight by burning up fat that you are already carrying, maintain your lower weight and minimise any weight regain. Losing even small amounts of weight and keeping it off produces additional health benefits for you, especially when you are at risk for other diseases such as heart disease and diabetes. Xenical can also help to improve risk factors, such as high blood pressure, high cholesterol and high blood sugar. If these are not treated, they could lead to other diseases such as hypertension and diabetes. Xenical should be taken in conjunction with a well-balanced calorie-controlled diet and other appropriate measures such as exercise.Active Ingredients:Xenical does not contain sucrose, gluten, tartrazine or any other azo dyes. Active ingredient - orlistat each Xenical capsule contains 120 mg orlistatInactive ingredients
DirectionsTake 1 capsule with each of the 3 main meals per day. It can be taken during the meal or up to 1 hour after the meal is consumed.Warnings & Disclaimers
*** Please note that this product is a Scheduled Medicine in Western Australia. In order to ensure this product is appropriate and safe for you to use, we would appreciate it if you could respond to the following questions for us.
Who is this product for (Age and gender)?
What were you using this medication to treat?
Has the person used this medication before?
Is the person who will use this product taking any other medications? Please include any herbal or vitamin supplements.
Does the person who will use this product have any medical conditions? Please list any medical conditions.
Please send a reply with your order number after purchase, to. Please note that if we are unable to contact your to verify the appropriateness of this product, your order may be cancelled and you will be refunded in full.
For more information on Scheduled Medicines, please see the link below https://ww2.health.wa.gov.au/Articles/S_T/Sale-and-supply-by-schedule
Active IngredientsDirectionsActive ingredientsContains 120 mg of orlistat. is the active ingredient. It is also available in 3 main concentrations:
Do not take this product if you are allergic to it or if you have any other allergies.
How long have I been using this product for?
Has the person used this product for any reason? Please include any medical condition.
What, if any, foods, alcohol or drug affected the effect of this product on the person who will use this product? This is a medical condition and not a controlled substance.
If you’re new to weight loss treatments and want to learn more about them, we’re here to help.
Tablets like (the brand name for Orlistat) work by reducing the amount of fat your body absorbs. Ordinarily, fats are broken down during the digestion process by enzymes called lipases. Xenical prevents these enzymes from working effectively, limiting how much fat your body is able to absorb. The remaining, undigested fat is then excreted.
In contrast to Xenical, weight loss injections (or pens) work by suppressing your appetite - particularly your appetite for fatty foods. Some weight loss injections also slow the digestion process down, making you feel fuller for longer. They’re simple to use - check out our for more information.
Clinical trials have repeatedly demonstrated the effectiveness of both weight loss tablets and injections, particularly in combination with a healthy diet and lifestyle., participants using lost almost 15% of their body weight over a 15-month period.
Starting your weight loss journey is simple with IQ Doctor. To begin, click on a product and then hit the 'Start Consultation' button. The online consultation process is quick, simple and free; just complete the form and we’ll verify whether the medication is suitable for you or not. If it is, you can then place your order and receive it the very next day.
TIP>If you have a prescription (or consulate) for Orlistat (or another weight loss medication), complete theMost authorities do not take this question as a guarantee of quality or safety, but rather as a request for repeat purchase. As with all medications, you should check to ensure that you are using the medication in its original potency.
Due to the identified differences in the pharmacology of the two tablets, the authorized person of the manufacturer may not be able to provide the product directly. For this reason, the supplied tablets must be manufactured by an authorized bodybuilder or health food retailer.
Crossreferving on the official Novartis website is
A list of all websites that offers weight loss products other than those listed in this page is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Your doctor may be able to offer treatment otherwise.
When you place your order, please ensure that the online pharmacy refers you to the appropriate pharmacy, especially if you have a valid prescription from your healthcare provider. The pharmacy will check in with you prior to providing you with your product. If they do not yet, they may be able to offer you a alternative pharmacy.
You should also complete the online consultation process and then consult with the healthcare provider you were prescribed. They’ll be able to advise you regarding your best strategy for obtaining this medication and any potential side effects you may experience. If they don’t yet, you may be asked to try another weight loss medication.
All of our content is published with thanks granted to the original authors.
with with withLamson Institute for the Study of Obesity. Aims: Aims: This research study investigates the efficacy of combination treatment of Orlistat and Orlistat-B for the treatment of overweight and obesity in men with type 2 diabetes mellitus. Methods: The study included consecutive men who have a body mass index (BMI) ≥27 kg/m2 for the past 12 months and who are either stable on orlistat (N=1940) or placebo (N=2080). Treatment was started at a fixed dose of 1 mg and continued for 12 weeks. The study was double-blinded and, if appropriate, the treatment was stopped when patients reported significant improvement in the BMI and BMI-changes after 12 weeks of treatment. Results: Baseline data were incomplete. A total of 391 patients were evaluated; 870 patients on orlistat were included in the main analysis. In the subgroup with more than 1 BMI increase over baseline (body mass index ≥30 kg/m2), the overall treatment success rate was 89% (95% confidence interval: 70-100%): 2.5% on orlistat and 1% on placebo. A significant improvement was observed in the change from baseline to 12 weeks, with a mean change of -0.5 kg/m2 (95% confidence interval: -1.3 to -0.6 kg/m2) on orlistat versus -1.5 kg/m2 (95% CI: -1.5 to -0.6 kg/m2). The mean change from baseline to 12 weeks was -1.7 kg/m2 (95% CI: -2.8 to -1.7 kg/m2) for orlistat versus -1.7 kg/m2 (95% CI: -2.9 to -1.8 kg/m2). In the subgroup of patients with a BMI of ≥30 kg/m2 for 12 weeks, the change from baseline to 12 weeks was -0.9 kg/m2 (95% CI: -1.2 to -0.2 kg/m2) for orlistat versus -0.7 kg/m2 (95% CI: -1.7 to -0.8 kg/m2) for placebo.
Controlled studyIn the main analysis, patients with type 2 diabetes were more likely to be female (27 vs 9%), consume less than normal body weight (23 vs 15%), smoke more than usual (5% vs 1%) and consume more than usual (10% vs 0%) than men on orlistat. The percentage of women was higher for orlistat than for placebo. In the subgroup with a BMI ≥30 kg/m2 for 12 weeks, the overall treatment success rate was 89% (95% CI: 70-100%): 2.5% on orlistat and 1% on placebo. In the subgroup with a BMI of ≥30 kg/m2 for 12 weeks, the overall treatment success rate was 100% (95% CI: 70-100%): 2.5% on orlistat and 1% on placebo. A significant improvement was observed in the change from baseline to 12 weeks, with a mean change of -0.5 kg/m2 (95% CI: -1.3 to -0.6 kg/m2) on orlistat versus -1.5 kg/m2 (95% CI: -1.5 to -0.6 kg/m2) for placebo. In the subgroup of patients with a BMI of ≥30 kg/m2 for 12 weeks, the change from baseline to 12 weeks was -1.7 kg/m2 (95% CI: -2.8 to -1.7 kg/m2) for orlistat versus -1.7 kg/m2 (95% CI: -2.9 to -1.8 kg/m2) for placebo. There was a significant improvement in the change from baseline to 12 weeks from 0.8 kg/m2 (95% CI: 0.6 to 1.4 kg/m2) to 0.8 kg/m2 (95% CI: 0.7 to 1.5 kg/m2) at 12 weeks. The subgroup with a BMI ≥30 kg/m2 for 12 weeks had a significantly larger change from baseline to 12 weeks (p<0.05) and a significantly larger change from baseline to 12 weeks (p<0.01).
Stade de France Pharmacy